Safety and Tolerability of BIII 890 in Patients With Acute Ischemic Stroke

Completed

Phase 2 Results N/A

Summary of Purpose

The objective of this study is to assess the safety, tolerability and pharmacokinetic characteristics of BIII 890 after intravenous infusion in acute ischemic stroke patients.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 25 September 2014.

1 Jul 2001 25 Sep 2014 1 Oct 2002 Unavailable 1 Sep 2014 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Conditions

Sponsors

Trial Design

  • Allocation: Randomized
  • Masking: Double-Blind
  • Purpose: Treatment
  • Intervention: Parallel Assignment

Contacts

Not available